MCID: CRN027
MIFTS: 47

Corneal Neovascularization malady

Category: Eye diseases

Aliases & Classifications for Corneal Neovascularization

About this section

Aliases & Descriptions for Corneal Neovascularization:

Name: Corneal Neovascularization 11 13 25 48 37 66

Classifications:



External Ids:

Disease Ontology11 DOID:11382
ICD1028 H16.4, H16.40
ICD9CM30 370.6, 370.60
MeSH37 D016510

Summaries for Corneal Neovascularization

About this section
Wikipedia:69 Corneal neovascularization is the excessive ingrowth of blood vessels from the limbal vascular plexus... more...

MalaCards based summary: Corneal Neovascularization is related to hypertrophy of tongue papillae and enamel erosion, and has symptoms including vascularization of cornea An important gene associated with Corneal Neovascularization is VEGFA (Vascular Endothelial Growth Factor A), and among its related pathways are Integrins in angiogenesis and Embryonic and Induced Pluripotent Stem Cell Differentiation Pathways and Lineage-specific Markers. Affiliated tissues include eye, endothelial and neutrophil, and related mouse phenotypes are reproductive system and liver/biliary system.

Related Diseases for Corneal Neovascularization

About this section

Diseases related to Corneal Neovascularization via text searches within MalaCards or GeneCards Suite gene sharing:

(show top 50)    (show all 72)
idRelated DiseaseScoreTop Affiliating Genes
1hypertrophy of tongue papillae10.7SERPINF1, VEGFA
2enamel erosion10.7FGF2, VEGFA
3spinal cord astrocytoma10.7FLT1, VEGFA
4spinal muscular atrophy-dandy-walker malformation-cataracts syndrome10.6FLT1, VEGFA
5ovarian fetiform teratoma10.6CXCL12, FGF2
6thrombophilia10.6SERPINF1, VEGFA
7intestinal benign neoplasm10.6FLT1, VEGFA
8acute lymphoblastic leukemia congenital sporadic aniridia10.6FLT1, VEGFA
9postural hypotension10.6FGF2, VEGFA
10facial nerve disease10.5SERPINF1, VEGFA
11speech disorder10.5FGF2, SERPINF1, VEGFA
12autoimmune polyendocrine syndrome10.4CD36, VEGFA
13burns10.4
14cyclothymic disorder10.4TEK, VEGFA
15endotheliitis10.4
16vitreous abscess10.4FGF2, VEGFA
17pauciarticular onset juvenile idiopathic arthritis10.4CD36, VEGFA
18silicosiderosis10.4KDR, VEGFA
19malignant gastric germ cell tumor10.3KDR, VEGFA
20striatonigral degeneration10.3FLT1, TEK
21scn8a encephalopathy10.3SERPINF1, VEGFA
22arthrogryposis, ectodermal dysplasia, cleft lip/palate, and developmental delay10.3KDR, VEGFA
23iliac vein thrombophlebitis10.3KDR, VEGFA
24osteogenesis imperfecta, type ii10.3CD36, SERPINF1
25renal artery obstruction10.3CXCL12, KDR
26ocular melanoma10.3KDR, VEGFA
27keratitis10.3
28bone benign neoplasm10.2FGF2, TEK
29hemangioblastoma10.2FGF2, TEK
30acute dacryocystitis10.1KDR, SERPINF1, VEGFA
31calcaneonavicular coalition10.1KDR, SERPINF1, VEGFA
32acute bilateral depigmentation of the iris10.1FGF2, KDR, VEGFA
33gastric small cell carcinoma10.1FGF2, KDR, VEGFA
34perivascular epithelioid cell tumor10.1KDR, VEGFA
35bladder urachal carcinoma10.1FLT1, KDR, VEGFA
36lung carcinoma in situ10.1FGF2, KDR, VEGFA
37neuropathy, hereditary sensory, type ib10.1FGF2, KDR, VEGFA
38lens disease10.1FLT1, KDR, VEGFA
39lipoatrophy with diabetes, leukomelanodermic papules, liver steatosis, and hypertrophic cardiomyopathy10.1FLT1, KDR, VEGFA
40chikungunya10.1FLT1, KDR, VEGFA
41stromal keratitis10.1
42cystadenoma10.1FGF2, KDR, VEGFA
43naegeli-franceschetti-jadassohn syndrome/dermatopathia pigmentosa reticularis10.0FGF2, VEGFA
44intracranial hemorrhage in brain cerebrovascular malformations10.0FGF2, KDR, VEGFA
45osteogenesis imperfecta, type iii10.0CD36, SERPINF1
46diamond-blackfan anemia 310.0CD36, CXCL12, FGF2
47gorham's disease9.9FGF2, KDR, XBP1
48tollner horst manzke syndrome9.9FGF2, PLG, VEGFA
49epidermolysis bullosa9.9KDR, TEK, VEGFA
50keratopathy9.9

Graphical network of the top 20 diseases related to Corneal Neovascularization:



Diseases related to corneal neovascularization

Symptoms for Corneal Neovascularization

About this section

UMLS symptoms related to Corneal Neovascularization:


vascularization of cornea

Drugs & Therapeutics for Corneal Neovascularization

About this section

Drugs for Corneal Neovascularization (from DrugBank, HMDB, Dgidb, PharmGKB, IUPHAR, NovoSeek, BitterDB):

(show all 21)
idNameStatusPhaseClinical TrialsCas NumberPubChem Id
1
BevacizumabPhase 4, Phase 2, Phase 3, Phase 11938216974-75-3
Synonyms:
216974-75-3
Avastin
Avastin (TN)
Bevacizumab
Bevacizumab (genetical recombination)
 
Bevacizumab (genetical recombination) (JAN)
D06409
R-435
anti-VEGF monoclonal antibody
antiVEGF
bevacizumab
2
RanibizumabPhase 4, Phase 1469347396-82-1459903
Synonyms:
347396-82-1
D05697
Lucentis
Lucentis (TN)
 
Ranibizumab
Ranibizumab (USAN/INN)
Ranibizumab (genetical recombination)
Ranibizumab (genetical recombination) (JAN)
ranibizumab
rhuFab V2
3triamcinolone acetonidePhase 2, Phase 3463
4
TriamcinolonePhase 2, Phase 3463124-94-731307
Synonyms:
(8S,9R,10S,11S,13S,14S,16R,17S)-9-fluoro-11,16,17-trihydroxy-17-(2-hydroxyacetyl)-10,13-dimethyl-6,7,8,11,12,14,15,16-octahydrocyclopenta[a]phenanthren-3-one
11-beta,16-alpha,17-alpha,21-Tetrahydroxy-9-alpha-fluoro-1,4-pregnadiene-3,20-dione
11.Beta.,16.alpha.,17.alpha., 21-Tetrahydroxy-9.alpha.-fluoro-1,4-pregnadiene-3,20-dione
11.beta.,16.alpha.,17.alpha.,21-Tetrahydroxy-9.alpha.-fluoro-1,4-pregnadiene-3,20-dione
11β,16α,17α,21-tetrahydroxy-9α-fluoro-1,4-pregnadiene-3,20-dione
124-94-7
4-08-00-03629 (Beilstein Handbook Reference)
83474-03-7
9-Fluoro-11,16,17,21-tetrahydroxypregna-1,4-diene-3,20-dione
9-Fluoro-11beta,16alpha,17,21-tetrahydroxypregna-1,4-diene-3,20-dione
9-alpha-Fluoro-11-beta,16-alpha,17,21-tetrahydroxypregna-1,4-diene-3,20-dione
9-alpha-Fluoro-16-alpha-hydroxyprednisolone
9-fluoro-11β,16α,17,21-tetrahydroxypregna-1,4-diene-3,20-dione
9.Alpha.-Fluoro-11.beta.,16.alpha.,17,21-tetrahy
9.Alpha.-Fluoro-11.beta.,16.alpha.,17.alpha., 21-tetrahydroxypregna-1,4-diene-3,20-d
9.alpha.-Fluoro-11.beta.,16.alpha.,17,21-tetrahydroxy-1,4-pregnadiene-3,20-dione
9.alpha.-Fluoro-11.beta.,16.alpha.,17,21-tetrahydroxypregna-1,4-diene-3,20-dione
9.alpha.-Fluoro-11.beta.,16.alpha.,17.alpha.,21-tetrahydroxypregna-1,4-diene-3,20-dione
9.alpha.-Fluoro-16.alpha.-hydroxyprednisolone
9alpha-Fluoro-11beta,16alpha,17,21-tetrahydroxy-1,4-pregnadiene-3,20-dione
9alpha-Fluoro-11beta,16alpha,17,21-tetrahydroxypregna-1,4-diene-3,20-dione
9alpha-Fluoro-16alpha-hydroxyprednisolone
9α-fluoro-11β,16α,17,21-tetrahydroxypregna-1,4-diene-3,20-dione
9α-fluoro-11β,16α,17α,21-tetrahydroxypregna-1,4-diene-3,20-dione
9α-fluoro-16α-hydroxyprednisolone
AC-2072
AC1L1LDH
AC1Q5HJC
Adcortyl
Aristocort
Aristocort A
Aristocort Tablets
Aristogel
Aristospan
Azmacort
BPBio1_000154
BRD-K77554836-001-03-3
BRN 2341955
BSPBio_000140
Bio-0662
C21H27FO6
CHEMBL1451
CID31307
CL 19823
Celeste
Cinolone
Cinolone-T
D00385
D014221
DB00620
Delphicort
EINECS 204-718-7
EU-0101179
Fluoxiprednisolone
Fluoxyprednisolone
Flutex
Fougera
HMS1568G22
HMS2090D12
HSDB 3194
Kenacort
Kenacort (TN)
Kenacort-A
Kenacort-AG
Kenacort-Ag
Kenalog
Kenalog in Orabase
Kenalog-10
Kenalog-40
Kenalog-H
LS-698
Ledercort
Lopac0_001179
 
MLS000028542
MLS001066543
MLS002695935
MolPort-002-528-981
Mycolog
NCGC00021580-03
NCGC00021580-04
NCGC00021580-05
NCGC00021580-06
NCGC00021580-07
NCI60_000750
NSC 13397
NSC13397
Nasacort
Nasacort Aq
Nasacort Hfa
Omcilon
Omicilon
Oracort
Oralone
Orion
Polcortolon
Pregna-1,4-diene-3,20-dio
Pregna-1,4-diene-3,20-dione, 9-fluoro-11,16,17,21-tetrahydroxy-, (11beta,16alpha)
Pregna-1,4-diene-3,20-dione, 9-fluoro-11beta,16alpha,17,21-tetrahydroxy- (8CI)
Prestwick0_000120
Prestwick1_000120
Prestwick2_000120
Prestwick3_000120
Prestwick_438
Rodinolone
S1933_Selleck
SK-Triamcinolone
SMP1_000300
SMR000058333
SPBio_002079
Sk-Triamcinolone
T6376_SIGMA
TRIAMCINOLONE (SEE ALSO TRIAMCINOLONE ACETONIDE (76-25-5) AND TRIAMCINOLONE DIACETATE (67-78-7))
Tiamcinolonum
Tiamcinolonum [INN-Latin]
Tri-Nasal
Triacet
Triacort
Triam-Tablinen
Triamcet
Triamcinalone
Triamcinlon
Triamcinolon
Triamcinolona
Triamcinolona [INN-Spanish]
Triamcinolone (JP15/USP/INN)
Triamcinolone [USAN:INN:BAN:JAN]
Triamcinolone acetonide
Triamcinolone diacetate
Triamcinolone hexacetonide
Triamcinolonum
Triamcinolonum [INN]
Triatex
Tricortale
Triderm
Trilone
Tristoject
Trymex
UNII-1ZK20VI6TY
Vetalog
Volon
Volon A
WLN: L E5 B666 OV KU MUTJ A1 BF CQ E1 FV1Q FQ GQ
ZINC03882036
droxypregna-1,4-diene-3,20-dione
ione
nchembio.2007.53-comp7
triamcinolone
5
VoriconazolePhase 3127137234-62-971616
Synonyms:
(2R,3S)-2-(2,4-difluorophenyl)-3-(5-fluoropyrimidin-4-yl)-1-(1,2,4-triazol-1-yl)butan-2-ol
(2R,3S)-2-(2,4-difluorophenyl)-3-(5-fluoropyrimidin-4-yl)-1-(1H-1,2,4-triazol-1-yl)butan-2-ol
(AlphaR,betas)-alpha-(2,4-difluorophenyl)-5-fluoro-beta-methyl-alpha(1H-1,2,4-triazol-1-ylmethyl)-4-pyrimidineethanol
(R-(R*,S*))-alpha-(2,4-difluorophenyl)-5-fluoro-beta-methyl-alpha-(1H-1,2,4-triazol-1-ylmethyl)-4-pyrimidineethanol
(R-(R*,s*))-alpha-(2,4-difluorophenyl)-5-fluoro-beta-methyl-alpha-(1H-1,2,4-triazol-1-ylmethyl)-4-pyrimidineethanol
(alphaR,betaS)-alpha-(2,4-Difluorophenyl)-5-fluoro-beta-methyl-alpha-(1H-1,2,4-triazol-1-ylmethyl)-4-pyrimidineethanol
(alphaR,betaS)-alpha-(2,4-difluorophenyl)-5-fluoro-beta-methyl-alpha(1H-1,2,4-triazol-1-ylmethyl)-4-pyrimidineethanol
137234-62-9
173967-54-9
AC-823
AC1L2GHR
AC1Q4O6I
AKOS005145705
C07622
C102790
CHEBI:10023
CHEMBL638
CID71616
CPD000466350
D00578
DB00582
DRG-0301
FT-0082604
HMS2051N09
LS-181799
 
MLS000759464
MLS001424082
MolPort-003-850-863
Pfizer brand of voriconazole
S1442_Selleck
SAM001246664
SMR000466350
TL8000858
UK 109,496
UK 109496
UK-109,496
UK-109496
UNII-JFU09I87TR
VCZ
VRC
Vfend
Vfend (TN)
Vfend, Voriconazole
Voriconazol
Voriconazole
Voriconazole (JAN/USAN/INN)
Voriconazole [USAN:INN:BAN]
Voriconazole in combination with MGCD290
Voriconazolum
ZINC00014864
voriconazole
6
NatamycinPhase 387681-93-85281099
Synonyms:
(1R,3S,5R,7R,8E,12R,14E,16E,18E,20E,22R,24S,25R,26S)-22-[(3-amino-3,6-dideoxy-beta-D-mannopyranosyl)oxy]-1,3,26-trihydroxy-12-methyl-10-oxo-6,11,28-trioxatricyclo[22.3.1.0~5,7~]octacosa-8,14,16,18,20-pentaene-25-carboxylic acid
16-(3-Amino-3,6-didesoxy-beta-D-mannopyranosyloxy)-5,6-epoxy-8,12,14-trihydroxy-26-methyl-2,10-dioxo-1-oxacyclohexacosa-3,17,19,21,23-pentaen-13-carbonsaeure
6,11,28-Trioxatricyclo[22.3.1.05,7]octacosa-8,14,16,18,20-pentaene-25-carboxylic acid, 22-[(3-amino-3,6-dideoxy-.beta.-D-mannopyranosyl)oxy]-1,3,26-trihydroxy-12-methyl-10-oxo-, (1R,3S,5R,7R,8E,12R,14
7681-93-8
80482_FLUKA
A 5283
AC-15226
AC1LCW93
AC1MC3GI
Antibiotic A 5283
Antibiotic A-5283
C08073
C33H47NO13
CHEMBL1200656
CID657250
CL 12,625
CL 12625
CL-12625
CPD000466358
D00884
DB00826
Delvocid
Delvolan
Delvopos
E235
EINECS 231-683-5
HMS1571M10
LS-7662
MLS000069611
MLS000759475
MolPort-003-939-127
MolPort-005-935-314
Mycophyt
Myprozine
 
NATAMYCIN
Natacyn
Natacyn (TN)
Natafucin
Natamicina
Natamicina [INN-Spanish]
Natamycin
Natamycin (USP/INN)
Natamycin [USAN:INN:BAN]
Natamycin preparation
Natamycine
Natamycine [INN-French]
Natamycinum
Natamycinum [INN-Latin]
P0440_SIGMA
P9703_SIGMA
Pimafucin
Pimafugin
Pimaracin
Pimaricin
Pimaricin (JP15)
Pimaricin preparation
Pimaricine
Pimarizin
Pimarizin [German]
Prestwick2_001104
SAM001246683
SMP1_000240
SMR000058788
SMR000466358
Stereoisomer of 22-((3-amino-3,6-dideoxy-beta-D-mannopyranosyl)oxy)-1,3,26-trihydroxy-12-methyl-10-oxo-6,11,28-trioxatricyclo(22.3.1.0(sup 5,7))octacosa-8,14,16,18,20-pentaene-25-carboxylic acid
Synogil
Tennecetin
Tymasil
UNII-8O0C852CPO
pimaricin
7
MiconazolePhase 3, Phase 1357322916-47-84189
Synonyms:
(+-)-1-(2,4-Dichloro-beta-((2,4-dichlorobenzyl)oxy)phenethyl)imidazole
1-(2,4-Dichloro-beta-((2,4-dichlorobenzyl)oxy)phenethyl)imidazole
1-(2,4-dichloro-beta-((2,4-dichlorobenzyl)oxy)phenethyl) imidazole
1-[2,4-Dichloro- beta-([2,4-dichloro- benzyl]oxy)phenethyl]imidazole
1-[2-(2,4-Dichloro-benzyloxy)-2-(2,4-dichloro-phenyl)-ethyl]-1H-imidazole
1-[2-(2,4-Dichlorophenyl)-2-[(2,4-dichlorophenyl)methoxy]ethyl]-1H-imidazole
1-[2-(2,4-dichlorobenzyloxy)-2-(2,4-dichlorophenyl)ethyl]-1H-imidazole
1-[2-(2,4-dichlorophenyl)-2-[(2,4-dichlorophenyl)methoxy]ethyl]imidazole
1-[2-(2,4-dichlorophenyl)-2-{[(2,4-dichlorophenyl)methyl]oxy}ethyl]-1H-imidazole
1-{2-[(2,4-dichlorobenzyl)oxy]-2-(2,4-dichlorophenyl)ethyl}-1H-imidazole
22832-87-7 (NITRATE)
22916-47-8
75319-47-0
AB00053500
AC1L1HM1
AKOS001574474
Aflorix(nitrate)
Albistat(nitrate)
Andergin(nitrate)
BPBio1_000279
BRD-A82396632-001-03-0
BRD-A82396632-008-02-7
BRN 0965511
BSPBio_000253
BSPBio_002033
CCRIS 7924
CHEBI:6923
CHEMBL91
CID4189
CPD-4501
Conofite(nitrate)
D00416
DB01110
Dactarin
Daktarin IV
Daktarin iv
DivK1c_000156
EINECS 245-324-5
Epi-Monistat(nitrate)
Femizol-M
Florid(nitrate)
Gyno-Daktar(nitrate)
HMS1568M15
HMS2090B21
I14-14342
IDI1_000156
Imidazole, 1-(2-(2,4-dichlorophenyl)-2-((2,4-dichlorophenyl)methoxy)ethyl)- (9CI)
KBio1_000156
KBio2_001445
KBio2_004013
KBio2_006581
KBio3_001533
KBioGR_000581
KBioSS_001445
LS-78378
Lotrimin AF(nitrate)
MCZ
MJR 1762
MLS002222203
Micantin (nitrate)
Miconasil Nitrate
 
Miconazol
Miconazol [INN-Spanish]
Miconazole
Miconazole (JP15/USP/INN)
Miconazole 3
Miconazole 3 Combination Pack
Miconazole 7 Combination Pack
Miconazole [USAN:BAN:INN:JAN]
Miconazole nitrate salt
Miconazole-7
Miconazolo
Miconazolo [DCIT]
Miconazolum
Miconazolum [INN-Latin]
Micozole
Minostate
MolPort-002-557-553
Monazole 7
Monista (nitrate)
Monistat
Monistat (TN)
Monistat 1 Combination Pack
Monistat 3 Dual-Pak
Monistat 3 Vaginal Ovules
Monistat 5 Tampon
Monistat 7 Dual-Pak
Monistat 7 Vaginal Suppositories
Monistat Dual- PAK
Monistat IV
Monistat iv (TN)
Monistat iv (tn)
Monistat-Derm
NCI60_001353
NCI60_001380
NINDS_000156
NSC 170986
NSC169434
NSC170986
Novo-Miconazole Vaginal Ovules
Oprea1_091955
Prestwick0_000067
Prestwick1_000067
Prestwick2_000067
Prestwick3_000067
Prestwick_335
R 18134
R-14,889
SMR001307249
SPBio_000976
SPBio_002174
STK834405
STOCK1S-93556
Spectrum2_001048
Spectrum3_000507
Spectrum4_000061
Spectrum5_001297
Spectrum_000965
UNII-7NNO0D7S5M
Vusion
Zimycan
imidazole, 1-(2-(2,4-dichlorophenyl)-2-((2,4-dichlorophenyl) methoxy)ethyl)- (9CI)
miconazole
8
OxytetracyclinePhase 2, Phase 3879-57-25280972
Synonyms:
(2E,4S,4aR,5S,5aR,6S,12aS)-2-[amino(hydroxy)methylidene]-4-(dimethylamino)-5,6,10,11,12a-pentahydroxy-6-methyl-4,4a,5,5a-tetrahydrotetracene-1,3,12-trione
(2E,4S,6S,12aS)-2-[amino(hydroxy)methylidene]-4-(dimethylamino)-5,6,10,11,12a-pentahydroxy-6-methyl-4,4a,5,5a-tetrahydrotetracene-1,3,12-trione
(2Z)-2-[amino(hydroxy)methylidene]-4-(dimethylamino)-5,6,10,11,12a-pentahydroxy-6-methyl-4,4a,5,5a-tetrahydrotetracene-1,3,12-trione
(2Z,4S,4aR,5S,5aR,6S,12aS)-2-[amino(hydroxy)methylidene]-4-(dimethylamino)-5,6,10,11,12a-pentahydroxy-6-methyl-4,4a,5,5a-tetrahydrotetracene-1,3,12-trione
(4S,4aR,5S,5aR,6S,12aS)-4-(dimethylamino)-3,5,6,10,12,12a-hexahydroxy-6-methyl-1,11-dioxo-1,4,4a,5,5a,6,11,12a-octahydrotetracene-2-carboxamide
102287-29-6
103351-03-7
105145-10-6
106216-57-3
1405-95-4
15251-48-6
2058-46-0 (Mono-hydrochloride)
2058-46-0 (mono-hydrochloride)
21645-09-0
4-14-00-02633 (Beilstein Handbook Reference)
5-Hydroxy-Tetracycline
5-Hydroxytetracycline
52214-46-7
6153-64-6 (Di-hydrate)
6153-64-6 (di-hydrate)
6153-65-7 (Di-hydrochloride salt, di-hydrate)
6153-65-7 (di-hydrochloride salt, di-hydrate)
64038-91-1 (sulfate (2:1))
69766-62-7 (hydrochloride salt)
7179-50-2 (Calcium (1:1) salt)
7179-50-2 (calcium (1:1) salt)
79-57-2
79-57-2 (ANHYDROUS)
856305-69-6
96310-42-8
AC-12777
AC1NQXTY
AC1NQZMP
AC1NS4NE
AC1O52HP
AKOS001632631
Abbocin
Adamycin
Antibiotic TM 25
BPBio1_000302
BRN 2714587
BSPBio_000274
BSPBio_002151
Berkmycen
Biostat
Biostat PA
Biostat pa
Bisolvomycin
C06624
C22H24N2O9
CHEBI:27701
CHEMBL1517
CID5280972
CID5282186
CID5353856
CID6426716
DB00595
Dabicycline
Dalimycin
DivK1c_000225
EINECS 201-212-8
Embryostat
Fanterrin
Galsenomycin
Geomycin
Geomycin (Streptomyces vimosus)
Geotilin
HSDB 3145
Hydroxytetracycline
Hydroxytetracyclinum
IDI1_000225
Imperacin
KBio1_000225
KBio2_001535
KBio2_004103
KBio2_006671
KBio3_001651
KBioGR_000912
KBioSS_001535
LA 200
LMPK07000005
LS-93860
Lenocycline
Liquamycin
Liquamycin LA 200
 
MLS000069429
Macocyn
Medamycin
Mepatar
MolPort-002-524-946
MolPort-005-934-326
Mycoshield TMQTHC 20
NCGC00091268-04
NCGC00091268-05
NCI-C56473
NINDS_000225
NSC 9169
NSC-9169
NSC9169 (HCL)
OTC
OTC (antibiotic)
Oksisyklin
Ossitetraciclina
Ossitetraciclina [DCIT]
Oxacycline
Oxitetraciclina
Oxitetraciclina [INN-Spanish]
Oxitetracyclin
Oxitetracycline
Oxitetracyclinum
Oxy-kesso-tetra
Oxydon
Oxymycin
Oxymykoin
Oxypam
Oxysteclin
Oxyterracin
Oxyterracine
Oxyterracyne
Oxytetracid
Oxytetracyclin
Oxytetracycline (anhydrous)
Oxytetracycline (internal use)
Oxytetracycline HCl
Oxytetracycline [INN]
Oxytetracycline [inn]
Oxytetracycline amphoteric
Oxytetracycline anhydrous
Oxytetracycline calcium
Oxytetracyclinum
Oxytetracyclinum [INN-Latin]
Oxytétracycline
Pennox 200
Prestwick0_000307
Prestwick1_000307
Prestwick2_000307
Prestwick3_000307
Proteroxyna
Riomitsin
Ryomycin
S1773_Selleck
SMR000059000
SPBio_001055
SPBio_002493
STOCK1N-50853
Solkaciclina
Spectrum2_000988
Spectrum3_000536
Spectrum4_000466
Spectrum5_001148
Spectrum_001055
Stecsolin
Stevacin
TM 5
Tarocyn
Tarosin
Teravit
Terrafungine
Terramitsin
Terramycin
Terramycin Q50
Terramycin im
Terramycin, Liquamycin, Oxytetracycline
Tetran
UNII-SLF0D9077S
UNII-X20I9EN955
Unimycin
Ursocyclin
Ursocycline
Vendarcin
oxytetracycline
9
DoxycyclinePhase 2, Phase 3232564-25-054671203
Synonyms:
(2E,4S,4aR,5S,5aR,6R,12aS)-2-[amino(hydroxy)methylidene]-4-(dimethylamino)-5,10,11,12a-tetrahydroxy-6-methyl-4a,5,5a,6-tetrahydro-4H-tetracene-1,3,12-trione
(2Z)-2-[amino(hydroxy)methylidene]-4-(dimethylamino)-5,10,11,12a-tetrahydroxy-6-methyl-4a,5,5a,6-tetrahydro-4H-tetracene-1,3,12-trione
(2Z,4S,4aR,5S,5aR,6R)-2-[amino(hydroxy)methylidene]-4-(dimethylamino)-5,10,11,12a-tetrahydroxy-6-methyl-4a,5,5a,6-tetrahydro-4H-tetracene-1,3,12-trione
(2Z,4S,4aR,5S,5aR,6R,12aS)-2-[amino(hydroxy)methylidene]-4-(dimethylamino)-5,10,11,12a-tetrahydroxy-6-methyl-4a,5,5a,6-tetrahydro-4H-tetracene-1,3,12-trione
(4S,4AR,5S,5ar,6R,12as)-4-(dimethylamino)-3,5,10,12,12a-pentahydroxy-6-methyl-1,11-dioxo-1,4,4a,5,5a,6,11,12a-octahydrotetracene-2-carboxamide
(4S,4aR,5S,5aR,6R,12aS)-4-(dimethylamino)-3,5,10,12,12a-pentahydroxy-6-methyl-1,11-dioxo-1,4,4a,5,5a,6,11,12a-octahydrotetracene-2-carboxamide
10597-92-9
17086-28-1 (mono-hydrate)
2-Naphthacenecarboxamide, 4-(dimethylamino)-1,4,4a,5,5a,6,11,12a-octahydro-3,5,10,12,12a-pentahydroxy-6-methyl-1,11-dioxo-, (4S,4aR,5S,5aR,6R,12aS)
24390-14-5
41411-66-9 (6-epimer, mono-hydrochloride)
5-Hydroxy-alpha-6-deoxytetracycline
564-25-0
6-Deoxyoxytetracycline
6-Deoxytetracycline
6-alpha-Deoxy-5-oxytetracycline
6-alpha-deoxy-5-oxytetracycline
69935-17-7 (mono-hydrochloride, di-hydrate)
6alpha-Deoxy-5-oxytetracycline
6α-deoxy-5-oxytetracycline
7164-70-7
7264-10-0
94088-85-4 (calcium salt (1:2))
AB08 (*Fosfatex)
AC1NQXW7
AC1NS4CW
AC1NUYS8
AC1O8PYM
Alti-Doxycycline
Apo-Doxy
Atridox
Azudoxat
BCBcMAP01_000024
BIDD:GT0146
BMY-28689
BPBio1_000951
BSPBio_000863
BSPBio_001936
BU-3839T
C06973
CHEBI:50845
CHEMBL1433
CID5281011
CID5353597
CID5463943
CID6713981
CPD001550033
D07876
DB00254
DMSC (*Fosfatex)
DOXCYCLINE ANHYDROUS
DOXY
DOXYCYCLINE CALCIUM
DOXYCYCLINE MONOHYDRATE
Deoxymykoin
DivK1c_000345
Dossiciclina
Dossiciclina [DCIT]
Doxcycline anhydrous
Doxiciclina
Doxiciclina [INN-Spanish]
Doxiciclina [Italian]
Doxitard
Doxivetin
Doxy-Caps
Doxy-Puren
Doxy-Tabs
Doxycen
Doxychel
Doxychel (TN)
Doxycin
Doxycyclin
Doxycycline (200mg/day) or Placebo
Doxycycline (INN)
 
Doxycycline (TN)
Doxycycline (anhydrous)
Doxycycline (internal use)
Doxycycline Hyclate
Doxycycline Monohydrate
Doxycycline anhydrous
Doxycycline hyclate
Doxycycline-Chinoin
Doxycyclinum
Doxycyclinum [INN-Latin]
Doxysol
Doxytec
Doxytetracycline
EINECS 209-271-1
GS-3065 (*monohydrate)
HMS2090E06
HSDB 3071
Hydramycin
IDI1_000345
Investin
Jenacyclin
KBio1_000345
KBio2_001287
KBio2_003855
KBio2_006423
KBio3_001156
KBioGR_001133
KBioSS_001287
LS-187766
LS-93868
Liviatin
Lopac0_000405
MolPort-002-507-423
Monodox
Monodox (*monohydrate)
NCGC00161602-01
NCGC00161602-03
NCGC00161602-04
NCGC00167961-01
NCGC00179395-01
NINDS_000345
NSC633557
Novo-Doxylin
Nu-Doxycycline
Oracea
Prestwick0_000852
Prestwick1_000852
Prestwick2_000852
Prestwick3_000852
Ronaxan
SAM002589932
SMP1_000107
SPBio_000246
SPBio_002784
STOCK1N-34341
Spanor
Spectrum2_000143
Spectrum3_000408
Spectrum4_000527
Spectrum5_000947
Spectrum_000807
Supracyclin
UNII-334895S862
UPCMLD-DP021
UPCMLD-DP021:001
Vibra-tabs
Vibramycin
Vibramycin (*monohydrate)
Vibramycin Novum
Vibramycine
Vibravenos
Vivox (*Hyclate)
alpha-6-Deoxy-5-hydroxytetracycline
alpha-6-Deoxyoxytetracycline
alpha-Doxycycline
doxycycline
10
PseudoephedrinePhase 156990-82-47028
Synonyms:
( )-Pseudoephedrine
(+)-(1S,2S)-Pseudoephedrine
(+)-Pseudoephedrine
(+)-Psi-ephedrine
(+)-psi-Ephedrine
(+)-threo-Ephedrine
(1S,2S)-(+)-Pseudoephedrine
(1S,2S)-2-(methylamino)-1-phenylpropan-1-ol
(1S,2S)-2-Methylamino-1-phenyl-1-propanol
(1S,2S)-Pseudoephedrine
(1S,2S)-Pseudoephedrine, polymer-bound
1-Ephedrine
2-(Methylamino)-1-phenyl-1-propanol
287636_ALDRICH
304-87-0
30987-59-8
37577-31-4
649031_ALDRICH
90-82-4
AC-20292
AC1L1NUA
Acunaso
Acunaso (TN)
Afrinol
BIDD:GT0817
BRD-K84175871-003-02-2
BSPBio_003261
Balminil Decongestant Syrup
Benylin Decongestant
Benzenemethanol, alpha-((1S)-1-(methylamino)ethyl)-, (alpha-S)- (9CI)
Besan
C02765
C10H15NO
CHEBI:51209
CHEMBL1590
CID7028
CPD-9954
Cenafed
D-Isoephedrine
D-Pseudoephedrine
D-Pseudoephedrine base
D-Psi-2-Methylamino-1-phenyl-1-propanol
D-Psi-2-methylamino-1-phenyl-1-propanol
D-Psi-Ephedrine
D-Psi-ephedrine
D08449
DB00852
Decofed
Dimetapp Decongestant
Dimetapp Decongestant Pediatric Drops
DivK1c_000451
Drixoral N.D.
Drixoral Nasal Decongestant
EINECS 202-018-6
Efidac 24 Pseudoephedrine Hcl
Efidac/24
Eltor 120
Ephedrine
Genaphed
HSDB 3177
I01-8928
IDI1_000451
 
Isoephedrine
KBio1_000451
KBio2_001358
KBio2_003926
KBio2_006494
KBio3_002762
KBioGR_001763
KBioSS_001358
L(+)-Psi-Ephedrine
L(+)-Psi-ephedrine
L(+)-psi-Ephedrine
L-(+)-Pseudoephedrine
LS-125922
Lopac-E-3250
Maxenal
MolPort-001-684-474
Myfedrine
NCGC00015408-01
NCGC00178180-01
NCI60_002955
NINDS_000451
Neodurasina
Neodurasina (TN)
Novafed
PDSP1_001347
PSEUDOEPHEDRINE
Pedia Care
Pseudo
Pseudo 60's
Pseudo-12
Pseudoefedrina
Pseudoefedrina [INN-Spanish]
Pseudoephedrine
Pseudoephedrine (D)
Pseudoephedrine (INN)
Pseudoephedrine D-form
Pseudoephedrine Ephedrine
Pseudoephedrine [INN:BAN]
Pseudoephedrine d-form
Pseudoephedrinum
Pseudoephedrinum [INN-Latin]
Psi-ephedrin
Psi-ephedrine
Robidrine
SPBio_001365
STOCK1N-42675
Spectrum2_001303
Spectrum3_001771
Spectrum4_001162
Spectrum5_000650
Spectrum_000878
Sudafed
Sudafed Decongestant
Sudafed Decongestant 12 Hour
Sudafed Decongestant Extra Strength
Triaminic AM Decongestant Formula
Triaminic Infant Oral Decongestant Drops
UNII-7CUC9DDI9F
alpha-(1-(Methylamino)ethyl)benzyl alcohol
d-Isoephedrine
d-Pseudoephedrine
d-psi-2-Methylamino-1-phenyl-1-propanol
d-psi-Ephedrine
trans-Ephedrine
11
ZincPhase 121547440-66-632051, 23994
Synonyms:
30Zn
Cinc
Zinc
Zinc ion
 
Zincum
Zink
Zn
Zn(ii)
Zn2+
12insulinPhase 14401
13Betamethasone ValeratePhase 11652152-44-5
14
EphedrinePhase 1569299-42-39294
Synonyms:
( )-Pseudoephedrine
(+)-Ephedrin
(+)-Ephedrine
(+)-Pseudoephedrine
(+)-psi-Ephedrine
(+)-threo-Ephedrine
(+-)-Ephedrine
(-)-Ephedrine
(-)-Pseudoephedrine
(-)-psi-Ephedrine
(-)-threo-Ephedrine
(1R,2R)-Ephedrine
(1R,2S)-1-Phenyl-1-hydroxy-2-methylaminopropane
(1S,2R)-Ephedrine
(L)-EPHEDRINE
--EPHEDRINE
1-EPHEDRINE
1-Sedrin
134910_ALDRICH
287636_ALDRICH
287644_ALDRICH
299-42-3
304-87-0
30987-59-8
321-96-0
321-97-1
321-98-2
37577-31-4
38732-95-5
45261_FLUKA
4607-45-8
50-98-6
50906-05-3
53214-57-6
649031_ALDRICH
6912-63-6
7009-81-6
90-82-4
968-63-8
AC-20231
AC-20292
AC1L1JGK
AC1L1NUA
AC1L1RFA
AC1L1SR1
AC1L1T31
AC1L1Y3M
AC1O8JUO
AC1Q3XJE
AC1Q3XJM
AC1Q3XJN
AC1Q59F5
AC1Q7701
AI3-02761
AKOS000268842
AR-1A0126
AR-1I7143
Acunaso
Acunaso (TN)
Afrinol
Ambap299-42-3
BIDD:GT0817
BRN 3197916
BRN 4231286
BSPBio_001946
BSPBio_001968
BSPBio_003261
Benylin Decongestant
Besan
Biophedrin
C01575
C02765
C10H15NO
CHEBI:15407
CHEBI:51209
CHEMBL1590
CHEMBL211456
CHEMBL357080
CID11972440
CID5032
CID62946
CID6710657
CID7028
CID8650
CID9294
CID9457
CPD-9954
CPDD 0049
Cenafed
D00124
D08449
DB00852
DB01364
Decofed
DivK1c_000181
DivK1c_000451
DivK1c_000461
Drixoral N.D.
EINECS 202-017-0
EINECS 202-018-6
EINECS 206-080-5
EINECS 206-292-8
EINECS 206-293-3
Eciphin
Efedrin
Efidac/24
Eltor 120
Ephedral
Ephedremal
Ephedrin
Ephedrine
Ephedrine (TN)
Ephedrine (USP)
Ephedrine [USAN:BAN]
Ephedrine l-form
Ephedrital
Ephedrol
Ephedrosan
Ephedrotal
Ephedsol
Ephendronal
Ephoxamin
Fedrin
Genaphed
HSDB 3072
HSDB 3177
I-Sedrin
I01-3584
I01-8925
I01-8928
 
IDI1_000181
IDI1_000451
IDI1_000461
Isoephedrine
Jsp005664
KBio1_000181
KBio1_000451
KBio1_000461
KBio2_001358
KBio2_001500
KBio2_003926
KBio2_004068
KBio2_006494
KBio2_006636
KBio3_001188
KBio3_001446
KBio3_002762
KBioGR_001013
KBioGR_001763
KBioSS_001358
KBioSS_001500
KST-1A9168
Kratedyn
L(+)-psi-Ephedrine
L(-)-Ephedrine
L-(+)-Ephedrine
L-(-)-Ephedrine
L-Ephedrine
L-erythro-2-(Methylamino)-1-phenylpropan-1-ol
L000968
LS-125921
LS-125922
LS-43083
LS-63961
LS-63962
LS-63963
LS-63964
Lexofedrin
Lopac-E-3250
Lopac0_000501
MLS000069657
Manadrin
Mandrin
Maxenal
MolPort-001-684-474
MolPort-001-684-477
MolPort-001-684-478
MolPort-001-684-479
MolPort-001-769-085
Myfedrine
NCGC00015408-01
NCGC00015408-02
NCGC00162174-01
NCGC00178180-01
NCGC00178889-01
NCI-C55652
NCI60_002955
NINDS_000181
NINDS_000451
NINDS_000461
NSC 165609
NSC 170951
NSC 8971
NSC165609
NSC170951
NSC8971
Nasol
Neodurasina
Neodurasina (TN)
Oprea1_287330
PDSP1_000168
PDSP1_001106
PDSP1_001343
PDSP1_001345
PDSP1_001346
PDSP1_001347
PDSP2_000167
PDSP2_001090
PDSP2_001327
PDSP2_001329
PDSP2_001330
PDSP2_001331
PSEUDOEPHEDRINE
Pedia Care
Pseudo
Pseudo 60's
Pseudo-12
Pseudoefedrina
Pseudoephedrine (D)
Pseudoephedrinum
Psi-ephedrin
Psi-ephedrine
Robidrine
SMR000059174
SPBio_000214
SPBio_001365
SPBio_001377
ST023802
STK367993
STOCK1N-42675
Sanedrine
Spectrum2_000137
Spectrum2_001303
Spectrum2_001309
Spectrum3_000414
Spectrum3_000563
Spectrum3_001771
Spectrum4_000497
Spectrum4_001162
Spectrum5_000650
Spectrum5_000879
Spectrum5_001106
Spectrum_000878
Spectrum_001020
Sudafed
Sudafed Decongestant
UNII-03VRY66076
UNII-7CUC9DDI9F
UNII-GN83C131XS
Vencipon
WLN: QYR & Y1 & M1
WLN: QYR&Y1&M1
Zephrol
d-Ephedrine
d-Isoephedrine
d-Pseudoephedrine
d-psi-Ephedrine
l-Ephedrine
l-Pseudoephedrine
racephedrine
trans-Ephedrine
15
BetamethasonePhase 1165378-44-99782
Synonyms:
.beta.-Methasone
.beta.-Methasone alcohol
1,4-Pregnadiene-3,20-dione-9alpha-fluoro-16 beta-methyl-11 beta,17alpha,21-triol
16beta-Methyl-1,4-pregnadiene-9alpha-fluoro-11beta,17alpha,21-triol-3,20-dione
16β-Methyl-1,4-pregnadiene-9α-fluoro-11β,17α,21-triol-3,20-dione
24024-03-1
34166_FLUKA
34166_RIEDEL
378-44-9
4-08-00-03501 (Beilstein Handbook Reference)
9-Fluoro-11,17,21-trihydroxy-16-methylpregna-1,4-diene-3,20-dione
9-Fluoro-11-beta,17,21-trihydroxy-16-beta-methylpregna-1,4-diene-3,20-dione
9-Fluoro-11.beta.,17,21-trihydroxy-16.beta.-methylpregna-1,4-diene-3,20-dione
9-Fluoro-11beta,17,21-trihydroxy-16beta-methylpregna-1,4-diene-3,20-dione
9-Fluoro-16.beta.-methylprednisolone
9-Fluoro-16beta-methylprednisolone
9-Fluoro-16β-methylprednisolone
9-alpha-Fluoro-16-beta-methylprednisolone
9.alpha.-Fluoro-16.beta.-methylprednisolone
9alpha-Fluoro-16 beta-methyl-prednisolone
9alpha-Fluoro-16beta-methylprednisolone
9α-Fluoro-16β-methylprednisolone
AC1L1EYE
AC1L1TT4
AC1Q5HJZ
AKOS001582690
AR-1A7284
AR-1H5595
B1837
B7005_SIAL
B7005_SIGMA
B9675_SIAL
BIDD:PXR0047
BPBio1_000533
BRD-A35108200-001-04-7
BRD-K39188321-001-03-9
BRN 3176546
BSPBio_000483
Bebate
Becort
Bedifos
Betacorlan
Betacortril
Betadexamethasone
Betafluorene
Betamamallet
Betametasona
Betametasona [INN-Spanish]
Betametasone
Betametasone [DCIT]
Betamethasone
Betamethasone (JP15/USP/INN)
Betamethasone Base
Betamethasone Valearate
Betamethasone [USAN:BAN:INN:JAN]
Betamethasone [USAN:INN:BAN:JAN]
Betamethasone alcohol
Betamethasone cream
Betamethasonum
Betamethasonum [INN-Latin]
Betamethasonvalerat Mikron
Betamethazone
Betapredol
Betasolon
Betnelan
 
Betsolan
C22H29FO5
CHEBI:3077
CHEMBL632
CID3003
CID9782
CPD000339803
Celestene
Celeston
Celestona
Celestone
Celestone Syrup and Tablets
Celestone, Betadexamethasone, Flubenisolone, Sch-4831, NCS-39470, Betamethasone
Cellestoderm
Cidoten
D00244
D1961
DB00443
Desacort-Beta
EINECS 206-825-4
Flubenisolone
HMS1569I05
HSDB 3015
Hormezon
I06-0121
KST-1A3042
LS-118466
LT00441022
Luxiq
Luxiqo
MLS-0310139.0001
MLS000686794
MLS000859943
MLS001066413
MLS001332616
MLS002153244
Methazon
MolPort-003-845-025
MolPort-007-981-051
NCGC00164401-01
NCGC00164401-02
NSC 39470
NSC-39470
NSC39470
Prestwick0_000362
Prestwick1_000362
Prestwick2_000362
Prestwick3_000362
Prestwick_703
Rinderon
Rinderon (TN)
Rinderon A
S1500_Selleck
SAM002589959
SCH 4831
SCH-4831
SMP1_000043
SMR000058601
SMR000339803
SPBio_002404
UNII-9842X06Q6M
Valisone
Visubeta
ZINC03876136
beta-Methasone
beta-Methasone alcohol
betamethasone
16
TropicamidePhase 1221508-75-45593
Synonyms:
(+-)-N-Ethyl-2-phenyl-N-(4-pyridylmethyl)hydracrylamide
1508-75-4
5-22-09-00359 (Beilstein Handbook Reference)
AB00052120
AC-816
AC1L1KOZ
AC1Q5IFA
AR-1K6980
Akorn Brand of Tropicamide
Alcon Brand of Tropicamide
BPBio1_000303
BRD-A79672927-001-05-8
BRN 0285563
BSPBio_000275
BSPBio_002289
Bio-0810
Bistropamide
Bournonville Brand of Tropicamide
CHEMBL1200604
CID5593
CPD000058523
Cahill May Roberts Brand of Tropicamide
Chauvin Brand of Tropicamide
Colircusi Tropicamida
D00397
D014331
DB00809
DivK1c_000448
EINECS 216-140-2
EU-0101223
Epitromina
HMS1568N17
HMS1921I09
HMS2089M05
HMS2092A18
HMS501G10
I-Picamide
I06-0811
IDI1_000448
KBio1_000448
KBio2_001064
KBio2_003632
KBio2_006200
KBio3_001509
KBioGR_000873
KBioSS_001064
L001262
LS-28545
Lopac0_001223
MLS001306442
MLS002154240
Medical Ophthalmics Brand of Tropicamide
Minims tropicamide
MolPort-000-159-321
Mydral
Mydriacyl
Mydriacyl (TN)
Mydriafair
Mydriaticum
Mydrum
N-Ethyl-2-phenyl-N-(4-pyridylmethyl)hydracrylamide
N-Ethyl-2-phenyl-N-4-[-pyridyl-methyl]hydracrylamide
N-Ethyl-N-(4-pyridylmethyl)tropamid
N-Ethyl-N-(4-pyridylmethyl)tropamide
N-Ethyl-alpha-(hydroxymethyl)-N-(4-pyridinylmethyl)benzeneacetamide
N-ethyl-3-hydroxy-2-phenyl-N-(pyridin-4-ylmethyl)propanamide
NCGC00016065-03
NCGC00016065-08
 
NCGC00024866-02
NCGC00024866-03
NCGC00024866-04
NCGC00024866-05
NCGC00024866-06
NINDS_000448
Novartis Brand of Tropicamide
Ocu Tropic
Ocu-Tropic
OcuTropic
Ocumed Brand of Tropicamide
Ocusoft Brand of Tropicamide
Opticyl
Paremyd
Pharmafair Brand of Tropicamide
Prestwick0_000228
Prestwick1_000228
Prestwick2_000228
Prestwick3_000228
Prestwick_487
Rivex Brand of Tropicamide
Ro 1-7683
SAM002564235
SMP1_000304
SMR000058523
SPBio_000872
SPBio_002196
SPECTRUM1500599
STK934612
Spectro-Cyl
Spectrum2_000936
Spectrum3_000655
Spectrum4_000377
Spectrum5_001585
Spectrum_000584
Stulln Brand 1 of Tropicamide
Stulln Brand 2 of Tropicamide
T 9778
T9778_SIGMA
TL8001101
Triaminic DM
Tropicacyl
Tropicamid
Tropicamida
Tropicamida [INN-Spanish]
Tropicamide
Tropicamide (JP15/USP/INN)
Tropicamide Alcon Brand
Tropicamide Chauvin Brand
Tropicamide Faure
Tropicamide Minims
Tropicamide Monofree
Tropicamide Monohydrochloride, (R)-Isomer
Tropicamide Monohydrochloride, (S)-Isomer
Tropicamide Novartis Brand
Tropicamide Ocumed Brand
Tropicamide Pharmafair Brand
Tropicamide Rivex Brand
Tropicamide [USAN:INN:BANJAN]
Tropicamide, (+-)-Isomer
Tropicamide, (R)-Isomer
Tropicamide, (S)-Isomer
Tropicamidum
Tropicamidum [INN-Latin]
Tropikamid
Tropimil
UNII-N0A3Z5XTC6
Visumidriatic
n-ethyl-n-(g-picolyl)tropamide
tropicamide
17
Verteporfin86129497-78-5
Synonyms:
Verteporfin
 
Verteporfina
Verteporfinum
Vertéporfine
18PREDNISOLONE ACETATE1118
19glucocorticoids4756
20
Methylprednisolone111883-43-26741
Synonyms:
(6S,8S,9S,10R,11S,13S,14S,17R)-11,17-dihydroxy-17-(2-hydroxyacetyl)-6,10,13-trimethyl-7,8,9,11,12,14,15,16-octahydro-6H-cyclopenta[a]phenanthren-3-one
(6a,11b)-11,17,21-Trihydroxy-6-methylpregna-1,4-diene-3,20-dione
(6alpha,11beta)-11,17,21-Trihydroxy-6-methylpregna-1,4-diene-3,20-dione
(6α,11β)-11,17,21-trihydroxy-6-methylpregna-1,4-diene-3,20-dione
.DELTA.1-6.alpha.-Methylhydrocortisone
1-Dehydro-6alpha-methylhydrocortisone
1-dehydro-6alpha-Methylhydrocortisone
1-dehydro-6α-methylhydrocortisone
11-beta,17,21-Trihydroxy-6-alpha-methylpregna-1,4-diene-3,20-dione
11beta,17,21-Trihydroxy-6alpha-methylpregna-1,4-diene-3,20-dione
11beta,17alpha,21-Trihydroxy-6alpha-methyl-1,4-pregnadiene-3,20-dione
11beta,17alpha,21-Trihydroxy-6alpha-methylpregna-1,4-diene-3,20-dione
121673-01-6
4-08-00-03498 (Beilstein Handbook Reference)
46436_FLUKA
46436_RIEDEL
570-35-4
6 Methylprednisolone
6-Methylprednisolone
6-alpha-Methylprednisolone
6.alpha.-Methylprednisolone
6923-42-8
6alpha-Methyl-11beta,17alpha,21-trihydroxy-1,4-pregnadiene-3,20-dione
6alpha-Methyl-11beta,17alpha,21-triol-1,4-pregnadiene-3,20-dione
6alpha-Methylprednisolone
6alpha-methyl-11beta,17alpha,21-triol-1,4-pregnadiene-3,20-dione
83-43-2
AC1L1N7A
Artisone-Wyeth
Artisone-wyeth
BPBio1_000174
BRD-K35240538-001-03-1
BRN 2340300
BSPBio_000158
Besonia
Bio-0658
CHEBI:6888
CHEMBL650
CID6741
CPD000058330
D00407
D008775
DB00959
Depo-Medrol (acetate)
Dopomedrol
EINECS 201-476-4
Esametone
Firmacort
HMS1568H20
HMS2090B13
HSDB 3127
LMST02030178
LS-118498
Lemod
M0639_SIGMA
M1665
MEPRDL
MLS000028541
MLS001148159
MLS002207191
Medesone
Medixon
Medlone 21
 
Medrate
Medrol
Medrol (TN)
Medrol Adt Pak
Medrol Dosepak
Medrol adt pak
Medrol dosepak
Medrol, Solu-Medrol, Medrone, Methylprednisolone
Medrone
Mesopren
Metastab
Methyleneprednisolone
Methylprednisolon
Methylprednisolone
Methylprednisolone (JP15/USP/INN)
Methylprednisolone [USAN:INN:BAN:JAN]
Methylprednisolone, 6-alpha
Methylprednisolonum
Methylprednisolonum [INN-Latin]
Metilbetasone
Metilprednisolona
Metilprednisolona [INN-Spanish]
Metilprednisolone
Metilprednisolone [DCIT]
Metilprednisolone [Dcit]
Metipred
Metrisone
Metrocort
Metysolon
Moderin
MolPort-002-528-554
NCGC00022735-03
NCI60_001657
NSC-19987
NSC19987
Nirypan
Noretona
Predni N Tablinen
Prednol- L
Pregna-1,4-diene-3,20-dione, 11beta,17,21-trihydroxy-6alpha-methyl- (8CI)
Prestwick0_000279
Prestwick1_000279
Prestwick2_000279
Prestwick3_000279
Prestwick_622
Promacortine
Reactenol
S1733_Selleck
SAM002589984
SMR000058330
SPBio_002377
Sieropresol
Solomet
Summicort
Suprametil
U 7532
UNII-X4W7ZR7023
Urbason
Urbasone
Wyacort
ZINC03875560
delta(1)-6alpha-Methylhydrocortisone
delta(sup 1)-6-alpha-Methylhydrocortisone
methylprednisolone
methylprenisolone
21
Prednisolone111850-24-85755
Synonyms:
(11beta)-11,17,21-Trihydroxypregna-1,4-diene-3,20-dione
.DELTA.1-Cortisol
.DELTA.1-Dehydrocortisol
.DELTA.1-Dehydrohydrocortisone
.DELTA.1-Hydrocortisone
.delta.-Cortef
.delta.-Stab
1,2-Dehydrohydrocortisone
1,4-Pregnadiene-11beta,17alpha,21-triol-3,20-dione
1,4-Pregnadiene-3,20-dione-11beta,17alpha,21-triol
1-Dehydrocortisol
1-Dehydrohydrocortisone
3,20-dioxo-11beta,17alpha,21-Trihydroxy-1,4-pregnadiene
46656_FLUKA
46656_RIEDEL
50-24-8
58201-11-9
8056-11-9
AC-1773
AC1L1L2E
Ak-Pred
Ak-Tate
Alphadrol
Articulose-50
BPBio1_000164
BRD-K98039984-001-03-0
BRN 1354103
BSPBio_000148
Bio-0666
Bubbli-Pred
C07369
CCRIS 980
CHEBI:8378
CHEMBL131
CID5755
CO-Hydeltra
CPD000718761
Co-Hydeltra
Codelcortone
Cordrol
Cortalone
Cotogesic
Cotolone
D00472
D011239
DB00860
Decaprednil
Decortin H
Delcortol
Delta F
Delta(1)-dehydrohydrocortisone
Delta-Cortef
Delta-Cortef (TN)
Delta-Ef-Cortelan
Delta-Stab
Delta-stab
Deltacortenol
Deltacortril
Deltacortril Enteric
Deltahydrocortisone
Deltasolone
Deltisilone
Depo-Medrol
Derpo PD
Derpo Pd
Dexa-Cortidelt Hostacortin H
Dexa-Cortidelt hostacortin H
Di Adreson F
Di-Adreson F
Di-Adreson-F
Di-adreson F
DiAdresonF
Dicortol
Donisolone
Dydeltrone
EINECS 200-021-7
Eazolin D
Econopred
Econopred Plus
Erbacort
Erbasona
Estilsona
Fernisolone
Fernisolone P
Fernisolone-P
Flamasone
HMS1568H10
HMS2090J05
HSDB 3385
Hostacortin H
Hydeltra
Hydeltra-Tba
Hydeltrasol
Hydeltrone
Hydrodeltalone
Hydrodeltisone
Hydroretrocortin
Hydroretrocortine
I-Pred
Inflamase Forte
Inflamase Mild
K 1557
Key-Pred
Klismacort
LMST02030179
LS-7669
Lentosone
Lite Pred
M-Predrol
 
MLS001304083
MLS002154250
MLS002207037
Medrol
Medrol Acetate
Metacortandralone
Methylprednisolone Acetate
Meti-Derm
Meticortelone
Metreton
MolPort-002-507-147
NCGC00179649-01
NSC 9120
NSC9120
NSC9900
Neo-Delta-Cortef
Nisolone
Nor-Pred T.B.A.
Ocu-Pred
Ocu-Pred Forte
Ophtho-Tate
Orapred
P0152_SIGMA
P0637
P6004_SIGMA
PRDL
PRED-G
Panafcortelone
Paracortol
Paracotol
Pediapred
Poly-Pred
Precortalon
Precortancyl
Precortilon
Precortisyl
Pred Forte
Pred Mild
Predair
Predair A
Predair Forte
Predalone 50
Predalone T.B.A.
Predate
Predate Tba
Predate-50
Predcor-25
Predcor-50
Predcor-Tba
Predisolone Sodium Phosphate
Predne-Dome
Prednelan
Predni-Dome
Prednicen
Predniliderm
Predniretard
Prednis
Prednisolona
Prednisolona [INN-Spanish]
Prednisolone (JP15/USP/INN)
Prednisolone (anhydrous)
Prednisolone Acetate
Prednisolone Sodium Phosphate
Prednisolone Tebutate
Prednisolone [INN:BAN:JAN]
Prednisolonum
Prednisolonum [INN-Latin]
Predonin
Predonine
Prelone
Prenolone
Prestwick0_000274
Prestwick1_000274
Prestwick2_000274
Prestwick3_000274
Prestwick_404
Rolisone
S1737_Selleck
SAM002264639
SMR000718761
SPBio_002367
Scherisolon
Solone
Steran
Sterane
Sterolone
Supercortisol
UNII-9PHQ9Y1OLM
Ulacort
Ultra Pred
Ultracorten H
Ultracortene H
Ultracortene-H
Ultracortene-Hydrogen
Ultracortene-hydrogen
ZINC03833821
component of Ataraxoid
component of K-Predne-Dome
delta(1)-Cortisol
delta(1)-Dehydrocortisol
delta(1)-Dehydrohydrocortisone
delta(1)-Hydrocortisone
delta(sup 1)-Cortisol
delta(sup 1)-Dehydrocortisol
delta(sup 1)-Dehydrohydrocortisone
delta(sup 1)-Hydrocortisone
delta-dehydrocortisol
delta-dehydrohydrocortisone
delta-hydrocortisone
prednisolone

Interventional clinical trials:

(show top 50)    (show all 52)
idNameStatusNCT IDPhase
1The Effect of Bevacizumab on Corneal NeovascularizationCompletedNCT00797303Phase 4
2Clinical Performance of Biofinity Toric Versus Air Optix for AstigmatismCompletedNCT01965288Phase 4
3Efficacy and Safety of Autologous Cultivated Limbal Stem Cells Transplantation (ACLSCT) for Restoration of Corneal Epithelium in Patients With Limbal Stem Cell DeficiencyRecruitingNCT02577861Phase 4
4Strategies for Management of Corneal NeovascularisationNot yet recruitingNCT02594423Phase 4
5Evaluation of Changes in the Parameters of Optical Coherence Tomography After Intravitreal Injection of LucentisNot yet recruitingNCT01669447Phase 4
6Prospective Study to Determine the Effect of Subconjunctival Bevacizumab (AVASTIN) in Corneal NeovascularizationCompletedNCT00555594Phase 2, Phase 3
7The Role of Amniotic Membrane Transplantation in Ocular Chemical BurnsRecruitingNCT00370812Phase 2, Phase 3
8Efficacy and Safety Study of Avastin to Treat Neovascularisation of the CorneaRecruitingNCT01501760Phase 3
9Mycotic Antimicrobial Localized Injection for Treatment of Corneal UlcersActive, not recruitingNCT02731638Phase 3
10Low Dose Doxycycline in the Treatment of Corneal BurnNot yet recruitingNCT01886560Phase 2, Phase 3
11Treatment of Corneal Neovascularization With Topical PazopanibCompletedNCT01257750Phase 1, Phase 2
12Topical IL-1-Ra for Treatment of Corneal NeovascularizationCompletedNCT00915590Phase 1, Phase 2
13Safety and Efficacy of Bevacizumab in High-Risk Corneal Transplant SurvivalCompletedNCT01072357Phase 1, Phase 2
14Amniotic Membrane Graft In Syntomathic Bullous KeratopathyCompletedNCT01926535Phase 2
15Regenerative Medicine in Ocular Surface: Application of Cell Therapy for Ocular Surface Repair Using Progenitor Cells of Sclerocorneal Limbus Amplified ex VivoCompletedNCT01470573Phase 2
16Autologous Transplantation of Cultivated Limbal Stem Cells on Amniotic Membrane in Limbal Stem Cell Deficiency (LSD) PatientsCompletedNCT00736307Phase 1, Phase 2
17Investigation of Different Scanning Protocols for 3 Dimensional High-resolution Imaging of the Human Cornea With Optical Coherence Tomography (OCT) - A Pilot StudyRecruitingNCT01843101Phase 2
18A Multi-Center Study of the Safety and Efficacy of Bevacizumab in High-Risk Corneal Transplant SurvivalRecruitingNCT01996826Phase 1, Phase 2
19Treatment of Hereditary Hemorrhagic Telangiectasia of the Nasal Mucosa by Intranasal Bevacizumab : Search for Effective DoseRecruitingNCT02157987Phase 1, Phase 2
20Limbal Epithelial Stem Cell Transplantation: a Phase II Multicenter TrialRecruitingNCT02318485Phase 2
21Autologous Cultured Corneal Epithelium (CECA) for the Treatment of Limbal Stem Cell DeficiencyRecruitingNCT01756365Phase 1, Phase 2
22Bevacizumab for the Treatment of Corneal NeovascularizationActive, not recruitingNCT00992849Phase 2
23Cultivated Autologous Oral Mucosal Epithelial Transplantation for the Treatment of Ocular Surface DiseasesActive, not recruitingNCT02739113Phase 1, Phase 2
24Cultivated Stem Cell Transplantation for the Treatment of Limbal Stem Cell DeficiencyActive, not recruitingNCT00845117Phase 1, Phase 2
25Subconjunctival Aflibercept (EYLEA®) for the Treatment of Corneal NeovascularizationNot yet recruitingNCT02797704Phase 1, Phase 2
26Safety and Effectiveness of the RHCIII-MPC Biosynthetic Cornea in Patients Requiring Anterior Lamellar KeratoplastyNot yet recruitingNCT02424006Phase 1, Phase 2
27Transplantation of Cultivated Limbal Epithelium on Amniotic Membrane for Limbal Stem Cell DeficiencySuspendedNCT00348114Phase 2
28Topical Avastin for Treatment of Corneal NeovascularizationCompletedNCT00559936Phase 1
29Effectiveness and Safety of Topical Ranibizumab for Treatment of Corneal Neovascularization (NV)CompletedNCT00681889Phase 1
30Ranibizumab for the Inhibition of Neovascularization in the Cornea Following Corneal Transplant SurgeryCompletedNCT00769145Phase 1
31Topical Autologous Serum Application for the Treatment of Corneal Epithelium Defect After Ocular SurgeriesCompletedNCT01075347Phase 1
32Topical Autologous Insulin Application for the Treatment of Corneal Epithelium Defect After Ocular SurgeriesCompletedNCT01031888Phase 1
33Ranibizumab for the Inhibition of Neovascularization in PterygiaCompletedNCT00768963Phase 1
34The Improvement of Limbal Stem Cell Deficiency (LSCD) in Unilateral Stem Cell Damage by Amniotic Membrane Extract Eye Drop (AMEED)CompletedNCT02649621Phase 1
35Bevacizumab Injection for Recurrent PterygiumCompletedNCT02007174Phase 1
36Using Aflibercept Injection to Treat Blood Vessel Growth Over the CorneaTerminatedNCT01868360Phase 1
37Subconjunctival IVIg (Gamunex-C) Injection for Corneal Neovascularization and Inflammatory ConditionsWithdrawnNCT02042027Phase 1
38Evaluation of Biosynthetic Constructs to Replace Donor CorneasWithdrawnNCT02374723Phase 1
39Effectiveness and Safety of Topical Bevacizumab (Avastin) for Treatment of Corneal NeovascularizationCompletedNCT00512876
40Randomized Study of Photodynamic Therapy Using Dihematoporphyrin in Patients With Corneal NeovascularizationCompletedNCT00004430
41Photodynamic Therapy With Verteporfin for Corneal NeovascularizationCompletedNCT00471406
42Safety and Effectiveness of Subconjunctival Injection of Bevacizumab in the Treatment of Corneal NeovasculizationCompletedNCT00681603
43Vistakon Investigational Lens Worn as a Single Use Daily WearCompletedNCT01031004
44Assessment of Daily Disposable Silicone Hydrogel Lens WearCompletedNCT01093625
45Daily Disposable Silicone Hydrogel Contact Lens, Stenfilcon A, Clinical StudyCompletedNCT02637804
46Comparison of Subconjuctival Versus Topical Bevacizumab as Adjunct Therapy to TrabeculectomyCompletedNCT01425112
47Evaluation of an Investigational Multi-Purpose Disinfecting Solution for the Care of Silicone Hydrogel Soft Contact LensesCompletedNCT00382902
48Evaluation of an Investigational Multi-Purpose Disinfecting Solution for the Care of Soft Contact Lenses in Symptomatic PatientsCompletedNCT00382603
49Exploratory Clinical Trials of ACM-1 in the Treatment of Ophthalmological Neovascular DiseasesRecruitingNCT02448732Phase 0
50Neovascularization Patterns in Corneal Graft RejectionActive, not recruitingNCT01695655

Search NIH Clinical Center for Corneal Neovascularization


Cochrane evidence based reviews: corneal neovascularization

Genetic Tests for Corneal Neovascularization

About this section

Genetic tests related to Corneal Neovascularization:

id Genetic test Affiliating Genes
1 Corneal Neovascularization25

Anatomical Context for Corneal Neovascularization

About this section

MalaCards organs/tissues related to Corneal Neovascularization:

34
Eye, Endothelial, Neutrophil, Brain

Animal Models for Corneal Neovascularization or affiliated genes

About this section

MGI Mouse Phenotypes related to Corneal Neovascularization:

39 (show all 14)
idDescriptionMGI Source AccessionScoreTop Affiliating Genes
1MP:00053898.5CXCL12, FGF2, FLT1, PLG, ROBO1, SERPINF1
2MP:00053708.3CD36, CXCL12, KDR, PLG, VEGFA, XBP1
3MP:00053877.6CD36, CXCL12, FLT1, KDR, PLG, SERPINF1
4MP:00053817.5CD36, PLG, ROBO1, SERPINF1, SLIT2, VEGFA
5MP:00053907.5CD36, FGF2, KDR, ROBO1, SERPINF1, VEGFA
6MP:00053797.3CD36, PLG, ROBO1, SERPINF1, SLIT2, VEGFA
7MP:00053697.0CD36, CXCL12, FGF2, FLT1, KDR, ROBO1
8MP:00053916.9CD36, FGF2, FLT1, KDR, PLG, SERPINF1
9MP:00053976.9CD36, CXCL12, FGF2, FLT1, KDR, PLG
10MP:00053846.6CD36, CXCL12, FGF2, FLT1, KDR, PLG
11MP:00053766.4CD36, FGF2, FLT1, KDR, PLG, ROBO1
12MP:00053856.1CD36, CXCL12, FGF2, FLT1, KDR, PLG
13MP:00107686.0CD36, CXCL12, FGF2, FLT1, KDR, PLG
14MP:00036315.7CD36, CXCL12, FGF2, FLT1, KDR, PLG

Publications for Corneal Neovascularization

About this section

Articles related to Corneal Neovascularization:

(show top 50)    (show all 405)
idTitleAuthorsYear
1
Quantitative proteomic analysis of mice corneal tissues reveals angiogenesis-related proteins involved in corneal neovascularization. (27049463)
2016
2
Interleukin (IL)-17A Promotes Angiogenesis in an Experimental Corneal Neovascularization Model. (27419340)
2016
3
A Novel Peptide Derived from Tissue-Type Plasminogen Activator Potently Inhibits Angiogenesis and Corneal Neovascularization. (27618679)
2016
4
Corneal Angiography for Guiding and Evaluating Fine-Needle Diathermy Treatment of Corneal Neovascularization. (25841974)
2015
5
Therapeutic effects of topical netrin-4 inhibits corneal neovascularization in alkali-burn rats. (25853509)
2015
6
Effects of lapatinib and trastuzumab on vascular endothelial growth factor in experimental corneal neovascularization. (25640924)
2015
7
Keratocytes Create Stromal Spaces to Promote Corneal Neovascularization Via MMP13 Expression. (25190659)
2014
8
Critical Role of IP-10 on Reducing Experimental Corneal Neovascularization. (25309995)
2014
9
Clinico-biochemical correlation of the effect of subconjunctival bevacizumab for corneal neovascularization. (25090164)
2014
10
Quantification of corneal neovascularization after ex vivo limbal epithelial stem cell therapy. (25540752)
2014
11
Inhibitory Effect of Sub-conjunctival Tocilizumab on Alkali Burn Induced Corneal Neovascularization in Rats. (24910898)
2014
12
Angiopoietin-1 is regulated by miR-204 and contributes to corneal neovascularization in KLEIP-deficient mice. (24917145)
2014
13
Inhibition of corneal neovascularization by subconjunctival and topical bevacizumab and sunitinib in a rabbit model. (24145627)
2013
14
The inhibitory effect of thalidomide analogue on corneal neovascularization in rabbits. (23739149)
2013
15
Corneal neovascularization: An enigma. (24379562)
2013
16
The effect of different doses of subconjunctival bevacizumab injection on corneal neovascularization. (23404727)
2013
17
The association between corneal neovascularization and visual acuity: a systematic review. (22103683)
2013
18
Anti-VEGF Therapy (Bevacizumab) for Sulfur Mustard-Induced Corneal Neovascularization Associated with Delayed Limbal Stem Cell Deficiency in Rabbits. (24215293)
2013
19
Managements for corneal neovascularization. (24055908)
2013
20
Minocycline inhibits alkali burn-induced corneal neovascularization in mice. (22848638)
2012
21
Preliminary studies of the effects of vascular adhesion protein-1 inhibitors on experimental corneal neovascularization. (21331460)
2011
22
(-)-Epigallocatechin 3-gallate (EGCG) at the ocular surface inhibits corneal neovascularization. (20971568)
2011
23
Prevention of corneal neovascularization: comparison of different doses of subconjunctival bevacizumab with its topical form in experimental rats. (21212709)
2011
24
The effect of doxycycline temperature-sensitive hydrogel on inhibiting the corneal neovascularization induced by BFGF in rats. (20953876)
2011
25
Features of corneal neovascularization and lymphangiogenesis induced by different etiological factors in mice. (20640436)
2011
26
Suramab, a novel antiangiogenic agent, reduces tumor growth and corneal neovascularization. (20857116)
2011
27
Potential anti-angiogenic role of Slit2 in corneal neovascularization. (20298689)
2010
28
Inhibition of corneal neovascularization after alkali burn: comparison of different doses of bevacizumab in monotherapy or associated with dexamethasone. (21077280)
2010
29
The effect of bevacizumab on corneal neovascularization in rabbits. (20714387)
2010
30
A siRNA targeting vascular endothelial growth factor-A inhibiting experimental corneal neovascularization. (20450250)
2010
31
Enhanced experimental corneal neovascularization along with aberrant angiogenic factor expression in the absence of IL-1 receptor antagonist. (19458323)
2009
32
Short- and long-term safety profile and efficacy of topical bevacizumab (Avastin) eye drops against corneal neovascularization. (19415316)
2009
33
Combined use of superficial keratectomy and subconjunctival bevacizumab injection for corneal neovascularization. (18812781)
2008
34
Subconjunctival bevacizumab for corneal neovascularization in herpetic stromal keratitis. (18580272)
2008
35
Essential contribution of CCL3 to alkali-induced corneal neovascularization by regulating vascular endothelial growth factor production by macrophages. (18776949)
2008
36
Unique homologous siRNA blocks hypoxia-induced VEGF upregulation in human corneal cells and inhibits and regresses murine corneal neovascularization. (17198016)
2007
37
Alkali-induced corneal neovascularization is independent of CXCR2-mediated neutrophil infiltration. (17251813)
2007
38
Effects of corneal neovascularization on the manifestations of Avellino corneal dystrophy (granular corneal dystrophy type II). (17102666)
2006
39
Surgery-related factors influencing corneal neovascularization after low-risk keratoplasty. (16458678)
2006
40
Flt-1 intraceptors inhibit hypoxia-induced VEGF expression in vitro and corneal neovascularization in vivo. (15851564)
2005
41
Inhibition of corneal neovascularization by a peroxisome proliferator-activated receptor-gamma ligand. (15721625)
2005
42
Experimental inhibition of corneal neovascularization by endostatin gene transfection in vivo. (14687476)
2003
43
Corneal neovascularization after excimer keratectomy wounds in matrilysin-deficient mice. (12506066)
2003
44
Suppression of corneal neovascularization by conditioned culture medium of human amniotic membrane]. (14769230)
2003
45
Lipid hydroperoxide induced corneal neovascularization in hyperglycemic rabbits. (12518243)
2002
46
Macrophage inflammatory protein-2 and vascular endothelial growth factor regulate corneal neovascularization induced by infection with Pseudomonas aeruginosa in mice. (12121220)
2002
47
Topically applied water extract of propolis to suppress corneal neovascularization in rabbits. (10474071)
1999
48
Induction of conjunctival transdifferentiation on vascularized corneas by photothrombotic occlusion of corneal neovascularization. (2459642)
1988
49
Experimental corneal neovascularization: biomicroscopic, angiographic, and morphologic correlation. (2419029)
1985-1986
50
The effects of leukocyte depletion on corneal neovascularization. (621924)
1978

Variations for Corneal Neovascularization

About this section

Expression for genes affiliated with Corneal Neovascularization

About this section
Search GEO for disease gene expression data for Corneal Neovascularization.

Pathways for genes affiliated with Corneal Neovascularization

About this section

Pathways related to Corneal Neovascularization according to GeneCards Suite gene sharing:

(show all 30)
idSuper pathwaysScoreTop Affiliating Genes
19.6FGF2, KDR, VEGFA
29.6FGF2, KDR, VEGFA
3
Show member pathways
9.6FLT1, KDR, VEGFA
49.6FLT1, KDR, VEGFA
5
Show member pathways
9.6FLT1, KDR, VEGFA
6
Show member pathways
9.6FLT1, KDR, VEGFA
7
Show member pathways
9.6FLT1, KDR, VEGFA
8
Show member pathways
9.6FLT1, KDR, VEGFA
99.6FLT1, KDR, VEGFA
109.5FLT1, TEK, VEGFA
11
Show member pathways
9.5FLT1, KDR, TEK
129.5CXCL12, FGF2, PLG
139.3FGF2, FLT1, KDR, VEGFA
14
Show member pathways
9.3FGF2, FLT1, KDR, VEGFA
159.3FGF2, FLT1, KDR, VEGFA
169.3FGF2, KDR, PLG, VEGFA
17
Show member pathways
9.2FGF2, FLT1, KDR, TEK
189.2FGF2, FLT1, KDR, TEK
199.2FGF2, FLT1, SLIT2, VEGFA
20
Show member pathways
9.2CXCL12, FGF2, FLT1, KDR
21
Show member pathways
9.2CXCL12, FGF2, FLT1, KDR
229.1CXCL12, FLT1, TEK, VEGFA
239.1CXCL12, ROBO1, SLIT2
249.1CXCL12, ROBO1, SLIT2
25
Show member pathways
9.0FGF2, FLT1, KDR, TEK, VEGFA
269.0FGF2, FLT1, KDR, TEK, VEGFA
27
Show member pathways
9.0FGF2, FLT1, KDR, TEK, VEGFA
28
Show member pathways
8.5CXCL12, FGF2, FLT1, KDR, TEK, VEGFA
29
Show member pathways
8.5CXCL12, FGF2, FLT1, KDR, TEK, VEGFA
30
Show member pathways
7.8CD36, FGF2, KDR, ROBO1, SLIT2, TEK

GO Terms for genes affiliated with Corneal Neovascularization

About this section

Cellular components related to Corneal Neovascularization according to GeneCards Suite gene sharing:

idNameGO IDScoreTop Affiliating Genes
1cell surfaceGO:00099868.4CD36, PLG, ROBO1, TEK, VEGFA
2extracellular spaceGO:00056157.6CD36, CXCL12, FGF2, FLT1, PLG, SERPINF1
3extracellular regionGO:00055767.5CXCL12, FGF2, KDR, PLG, SERPINF1, SLIT2

Biological processes related to Corneal Neovascularization according to GeneCards Suite gene sharing:

(show all 41)
idNameGO IDScoreTop Affiliating Genes
1positive regulation of blood vessel endothelial cell migrationGO:004353610.6FGF2, VEGFA
2positive regulation of phospholipase C activityGO:001086310.6FGF2, FLT1
3positive regulation of vascular endothelial growth factor receptor signaling pathwayGO:003094910.6FLT1, VEGFA
4positive regulation of endothelial cell chemotaxis by VEGF-activated vascular endothelial growth factor receptor signaling pathwayGO:003803310.6KDR, VEGFA
5embryonic morphogenesisGO:004859810.5FGF2, FLT1
6positive regulation of positive chemotaxisGO:005092710.5KDR, VEGFA
7negative regulation of endothelial cell apoptotic processGO:200035210.4KDR, TEK
8branching morphogenesis of an epithelial tubeGO:004875410.4SLIT2, VEGFA
9induction of positive chemotaxisGO:005093010.3CXCL12, VEGFA
10chemorepulsion involved in postnatal olfactory bulb interneuron migrationGO:002183610.3ROBO1, SLIT2
11Roundabout signaling pathwayGO:003538510.2ROBO1, SLIT2
12positive regulation of axonogenesisGO:005077210.1ROBO1, SLIT2
13positive regulation of phosphatidylinositol 3-kinase activityGO:004355210.1FGF2, FLT1, TEK
14negative regulation of endothelial cell migrationGO:001059610.1SERPINF1, SLIT2
15negative regulation of chemokine-mediated signaling pathwayGO:007010010.1ROBO1, SLIT2
16positive regulation of focal adhesion assemblyGO:005189410.1KDR, TEK, VEGFA
17positive chemotaxisGO:005091810.1CXCL12, FGF2, VEGFA
18positive regulation of MAP kinase activityGO:004340610.0FGF2, FLT1, VEGFA
19positive regulation of axon extension involved in axon guidanceGO:004884210.0CXCL12, VEGFA
20cellular response to vascular endothelial growth factor stimulusGO:003592410.0FLT1, KDR, VEGFA
21negative regulation of inflammatory responseGO:00507289.9SERPINF1, SLIT2, TEK
22protein autophosphorylationGO:00467779.9FLT1, KDR, TEK
23positive regulation of endothelial cell migrationGO:00105959.9FGF2, KDR, TEK, VEGFA
24positive regulation of phosphatidylinositol 3-kinase signalingGO:00140689.9FLT1, KDR, TEK
25platelet degranulationGO:00025769.9CD36, PLG, VEGFA
26positive regulation of protein phosphorylationGO:00019349.8FGF2, KDR, TEK, VEGFA
27positive regulation of MAPK cascadeGO:00434109.7CD36, FLT1, KDR
28vascular endothelial growth factor receptor signaling pathwayGO:00480109.7FLT1, KDR, VEGFA
29endothelial cell proliferationGO:00019359.6TEK, XBP1
30peptidyl-tyrosine phosphorylationGO:00181089.6FGF2, FLT1, KDR, TEK
31transmembrane receptor protein tyrosine kinase signaling pathwayGO:00071699.6FLT1, KDR, TEK
32positive regulation of cell migrationGO:00303359.4CXCL12, FLT1, KDR, VEGFA
33positive regulation of angiogenesisGO:00457669.4FGF2, FLT1, KDR, TEK, VEGFA
34positive regulation of endothelial cell proliferationGO:00019389.4CXCL12, FGF2, KDR, TEK, VEGFA
35cell migration involved in sprouting angiogenesisGO:00020429.3FGF2, KDR, ROBO1, SLIT2, VEGFA
36response to hypoxiaGO:00016669.1CXCL12, FLT1, TEK, VEGFA
37axon guidanceGO:00074119.1CXCL12, ROBO1, SLIT2
38negative regulation of apoptotic processGO:00430668.9KDR, TEK, VEGFA, XBP1
39positive regulation of ERK1 and ERK2 cascadeGO:00703748.9CD36, FGF2, KDR, TEK
40positive regulation of cell proliferationGO:00082848.6CXCL12, FGF2, FLT1, KDR, VEGFA
41angiogenesisGO:00015258.5FGF2, FLT1, KDR, TEK, VEGFA, XBP1

Molecular functions related to Corneal Neovascularization according to GeneCards Suite gene sharing:

(show all 7)
idNameGO IDScoreTop Affiliating Genes
1vascular endothelial growth factor-activated receptor activityGO:000502110.4FLT1, KDR
2growth factor bindingGO:001983810.0FLT1, KDR, TEK
3chemoattractant activityGO:00420569.8CXCL12, FGF2, VEGFA
4heparin bindingGO:00082019.6FGF2, SLIT2, VEGFA
5growth factor activityGO:00080839.5CXCL12, FGF2, VEGFA
6protein tyrosine kinase activityGO:00047139.5FGF2, KDR, TEK
7transmembrane receptor protein tyrosine kinase activityGO:00047149.2FLT1, KDR, TEK

Sources for Corneal Neovascularization

About this section
2CDC
6CNVD
10DGIdb
15ExPASy
16FDA
17FMA
25GTR
26HGMD
27HMDB
28ICD10
29ICD10 via Orphanet
30ICD9CM
31IUPHAR
32KEGG
35MedGen
37MeSH
38MESH via Orphanet
39MGI
42NCI
43NCIt
44NDF-RT
47NINDS
48Novoseek
50OMIM
51OMIM via Orphanet
55PubMed
56QIAGEN
61SNOMED-CT via Orphanet
65Tumor Gene Family of Databases
66UMLS
67UMLS via Orphanet